In addition, exosome LGALS9 can regulate systemic anti-tumor immunity by inhibiting cytotoxic T-cell activation in cerebrospinal fluid and antigen presentation by dendritic cells (Wang et al., 2020). This evidence concerns the gene LGALS9 and neoplasm.